202 related articles for article (PubMed ID: 22315490)
1. CD34+ gene expression profiling of individual children with very severe aplastic anemia indicates a pathogenic role of integrin receptors and the proapoptotic death ligand TRAIL.
Fischer U; Ruckert C; Hubner B; Eckermann O; Binder V; Bakchoul T; Schuster FR; Merk S; Klein HU; Führer M; Dugas M; Borkhardt A
Haematologica; 2012 Sep; 97(9):1304-11. PubMed ID: 22315490
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers.
Zeng W; Chen G; Kajigaya S; Nunez O; Charrow A; Billings EM; Young NS
Blood; 2004 Jan; 103(1):325-32. PubMed ID: 14504100
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of interferon-gamma and tumor necrosis factor-alpha on CD34+ bone marrow progenitor cells from aplastic anemia patients and normal donors.
Welsh JP; Rutherford TR; Flynn J; Foukaneli T; Gordon-Smith EC; Gibson FM
Hematol J; 2004; 5(1):39-46. PubMed ID: 14745429
[TBL] [Abstract][Full Text] [Related]
4. A probable role for trail-induced apoptosis in the pathogenesis of marrow failure. Implications from an in vitro model and from marrow of aplastic anemia patients.
Kakagianni T; Giannakoulas NC; Thanopoulou E; Galani A; Michalopoulou S; Kouraklis-Symeonidis A; Zoumbos NC
Leuk Res; 2006 Jun; 30(6):713-21. PubMed ID: 16310248
[TBL] [Abstract][Full Text] [Related]
5. Adhesion molecule expression by bone marrow CD34-positive cells in aplastic anemia before and after immunosuppressive therapy.
Kaito K; Otsubo H; Ogasawara Y; Shimada T; Usui N; Kobayashi M
Clin Lab Haematol; 2003 Dec; 25(6):393-6. PubMed ID: 14641144
[TBL] [Abstract][Full Text] [Related]
6. TRAIL in CD8+ T cells from patients with severe aplastic anemia.
Liu C; Zheng M; Zhang T; Fu R; Wang H; Wang T; Qi W; Shao Z
Int J Hematol; 2017 Oct; 106(4):490-499. PubMed ID: 28631177
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
Manz CY; Nissen C; Wodnar-Filipowicz A
Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia.
de Vries AC; Langerak AW; Verhaaf B; Niemeyer CM; Stary J; Schmiegelow K; van Wering ER; Zwaan CM; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM
Leukemia; 2008 Jun; 22(6):1170-4. PubMed ID: 18323803
[TBL] [Abstract][Full Text] [Related]
9. [Influence of Shenmai injection on blood serum tumor necrosis factor and bone marrow CD34+ cell's apoptosis of chronic aplastic anemia patient].
Tang Q; Hu H; Zhang H
Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1296-8. PubMed ID: 16245914
[TBL] [Abstract][Full Text] [Related]
10. Fas/FasL in the immune pathogenesis of severe aplastic anemia.
Liu CY; Fu R; Wang HQ; Li LJ; Liu H; Guan J; Wang T; Qi WW; Ruan EB; Qu W; Wang GJ; Liu H; Wu YH; Song J; Xing LM; Shao ZH
Genet Mol Res; 2014 May; 13(2):4083-8. PubMed ID: 24938700
[TBL] [Abstract][Full Text] [Related]
11. P53 overexpression in bone marrow biopsies in refractory anemia and aplastic anemia: impact of antibody selection.
Elghetany MT
Leuk Res; 2000 Nov; 24(11):975-7. PubMed ID: 11086182
[TBL] [Abstract][Full Text] [Related]
12. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.
Otawa M; Kawanishi Y; Iwase O; Shoji N; Miyazawa K; Ohyashiki K
Leuk Res; 2000 Apr; 24(4):359-66. PubMed ID: 10713334
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
Matsui WH; Brodsky RA; Smith BD; Borowitz MJ; Jones RJ
Leukemia; 2006 Mar; 20(3):458-62. PubMed ID: 16437138
[TBL] [Abstract][Full Text] [Related]
14. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.
Townsley DM; Scheinberg P; Winkler T; Desmond R; Dumitriu B; Rios O; Weinstein B; Valdez J; Lotter J; Feng X; Desierto M; Leuva H; Bevans M; Wu C; Larochelle A; Calvo KR; Dunbar CE; Young NS
N Engl J Med; 2017 Apr; 376(16):1540-1550. PubMed ID: 28423296
[TBL] [Abstract][Full Text] [Related]
15. A plasma microRNA signature as a biomarker for acquired aplastic anemia.
Hosokawa K; Kajigaya S; Feng X; Desierto MJ; Fernandez Ibanez MD; Rios O; Weinstein B; Scheinberg P; Townsley DM; Young NS
Haematologica; 2017 Jan; 102(1):69-78. PubMed ID: 27658437
[TBL] [Abstract][Full Text] [Related]
16. Association of the interferon-gamma single nucleotide polymorphism +874(T/A) with response to immunosuppressive therapy in patients with severe aplastic anemia.
Chang H; Zeng F; Zhang JY; Mu XY; Meng WT; Ma HB; Liu T
Blood Cells Mol Dis; 2010 Dec; 45(4):313-6. PubMed ID: 20934357
[TBL] [Abstract][Full Text] [Related]
17. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
Chen G; Shao Z; Jia H
Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia.
Timeus F; Crescenzio N; Doria A; Foglia L; Linari A; Giaccone M; Pastore G; di Montezemolo LC; Ramenghi U; Saracco P
Exp Hematol; 2005 May; 33(5):597-604. PubMed ID: 15850838
[TBL] [Abstract][Full Text] [Related]
19. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia.
Nakao S; Yamaguchi M; Shiobara S; Yokoi T; Miyawaki T; Taniguchi T; Matsuda T
Blood; 1992 May; 79(10):2532-5. PubMed ID: 1586705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
